A Study to Evaluate TRS01 Eye Drops in Participants With Active Non-infectious Anterior Uveitis

Non-infectious Anterior Uveitis Clinical Trial

Official title:
A Randomized, Double-Masked, Dose-Ranging Study to Evaluate the Safety and Tolerability of TRS01 Eye Drops in Participants With Active Non-infectious Anterior Uveitis.

Status Completed

Clinical Trial Summary

The objective of this study is to evaluate the safety of TRS01 eye drops in participants with active non-infectious anterior uveitis .

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04222712
Study type	Interventional
Source	Tarsier Pharma
Contact
Status	Completed
Phase	Phase 1/Phase 2
Start date	February 1, 2020
Completion date	August 24, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05042609` - A Study of TRS01 in Subjects With Active Non-infectious Anterior Uveitis Including Subjects With Uveitic Glaucoma	Phase 3
Completed	`NCT02309385` - Safety and Efficacy Study of DSP-Visulex for the Treatment of Anterior Uveitis	Phase 1/Phase 2
Completed	`NCT02406209` - A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis	Phase 2
Not yet recruiting	`NCT04426734` - Evaluation of DEXTENZA in the Management of Pain and Inflammation in Patients With Anterior Uveitis Compared to Standard of Care Topical Corticosteroids	Phase 4
Completed	`NCT03131154` - SOLACE Trial - A Phase 3 Trial in Subjects With Non-infectious Anterior-uveitis.	Phase 3